Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

Pharmacy advocate groups are teaming up with lawmakers to get new legislation passed to stop monopolistic behaviors from Pharmacy Benefit Managers.

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

UnitedHealth Group reported mixed financial results for Q4, with a rise in medical care ratio and CEO's tribute to the late ...

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...

Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...

Humana has a strong position in the Medicare Advantage (MA) market and growth opportunities in its healthcare services business. The MA market is expanding rapidly as aging Americans seek ...

Amid intense criticism, UnitedHealth Group reported a $29 billion increase in 2024 revenues today, up 8% to $400.3 billion.

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Operator Good morning and welcome to the UnitedHealth Group fourth quarter and full year 2024 earnings conference call. A ...

UnitedHealth Group has reported quarterly profits of $5.5 billion after tax in its first earnings release since the killing ...